2014
Phone:
+44 20 8123 2220
Fax:
+44 207 900 3970 office@marketpublishers.com http://marketpublishers.com
Phone: +44 20 8123 2220 http://marketpublishers.com Vietnam Pharmaceuticals and Healthcare Report Q1 2014
Date:
Pages:
Price:
ID:
February 21, 2014
129
US$ 1,295.00
VB2D7A14C41EN
Includes 3 FREE quarterly updates
BMI View: The upgrade to our private healthcare forecast stems largely from the Vietnamese government's plan to pass hospital operating costs to patients. We highlight that this is potentially regressive should hospitals attempt to profit from such policies. Nevertheless, we remain largely optimistic towards Vietnam's healthcare sector, as it is seeking to implement universal healthcare for its population, which will improve access to services.
Headline Expenditure Projections
Pharmaceuticals: VND59,214bn (US$2.84bn) in 2012 to VND69,297bn (US$3.32bn) in 2013;
+17.0% in local currency terms and +16.9% in US dollar terms. Forecast unchanged from Q413, long-term forecast slightly upgraded to reflect general bullish sentiments in Vietnam's economy.
Healthcare: VND201,466bn (US$9.65bn) in 2012 to VND230,985bn (US$11.1bn) in 2013; +14.7% in local currency terms and +14.5% in US dollar terms. Forecast broadly in line with Q313.
Table of Content
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales Indicators, 2009-2017
Healthcare Market Forecast
Table: Healthcare Expenditure Indicators, 2009-2017
Table: Healthcare Governmental Indicators, 2009-2017
Table: Healthcare Private Indicators, 2009-2017
Prescription Drug Market Forecast
Table: Prescription Drug Sales Indicators, 2009-2017
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, 2009-2017
Generic Drug Market Forecast
Table: Generic Drug Sales Indicators, 2009-2017
OTC Medicine Market Forecast
Table: OTC Medicine Sales Indicators, 2009-2017